Skip to main content
Top
Published in: Clinical Reviews in Allergy & Immunology 1/2017

01-02-2017

Gorham-Stout Disease: a Clinical Case Report and Immunological Mechanisms in Bone Erosion

Authors: Maria José Franco-Barrera, Maria Guadalupe Zavala-Cerna, Georgina Aguilar-Portillo, Diana Brisa Sánchez-Gomez, Olivia Torres-Bugarin, Miguel Angel Franco-Barrera, Carlos Manuel Roa-Encarnacion

Published in: Clinical Reviews in Allergy & Immunology | Issue 1/2017

Login to get access

Abstract

Gorham-Stout disease (GSD) is a rare condition of osteolysis with excessive lymphangiogenesis within bone tissue. The etiology of this condition remains unknown but seems to affect mainly children and young adults of both genders all over the world. Unfortunately, there is no standardized method for diagnosis; however, histopathology remains as the gold standard. This condition is often misdiagnosed due to its varying clinical presentations from case-to-case. Here, we report the case of an 8-year-old girl who presented with chronic mandibular pain during mastication and received multiple antibiotic treatment due to infectious origin suspicion. After integrating information from clinical manifestations, radiographic, laboratory, and histopathology information, she was diagnosed with GSD. Additionally, due to the lack of literature with respect to insights into biological mechanisms and standardized treatment for this condition, we underwent a literature revision to provide information related to activation of cells from the immune system, such as macrophages, T-cells, and dendritic cells, and their contribution to the lymphangiogenesis, angiogenesis, and osteoclastogenic process in GSD. It is important to consider these mechanisms in patients with GSD, especially since new studies performed in earlier stages are required to confirm their use as novel diagnostic tools and find new possibilities for treatment.
Literature
1.
go back to reference Ellati R et al (2016) Novel approach of treating Gorham-Stout disease in the humerus—case report and review of literature. Eur Rev Med Pharmacol Sci 20(3):426–432PubMed Ellati R et al (2016) Novel approach of treating Gorham-Stout disease in the humerus—case report and review of literature. Eur Rev Med Pharmacol Sci 20(3):426–432PubMed
3.
go back to reference Evrenos MK et al (2016) Case report: Gorham-Stoute syndrome with involvement of majority of mandible, and partial maxillary, temporal and zygomatic bones. J Maxillofac Oral Surg 15(Suppl 2):335–338CrossRefPubMed Evrenos MK et al (2016) Case report: Gorham-Stoute syndrome with involvement of majority of mandible, and partial maxillary, temporal and zygomatic bones. J Maxillofac Oral Surg 15(Suppl 2):335–338CrossRefPubMed
4.
go back to reference Ruggieri P et al (2011) Gorham-Stout disease: the experience of the Rizzoli Institute and review of the literature. Skelet Radiol 40(11):1391–1397CrossRef Ruggieri P et al (2011) Gorham-Stout disease: the experience of the Rizzoli Institute and review of the literature. Skelet Radiol 40(11):1391–1397CrossRef
5.
go back to reference Gorham LW, Stout AP (1955) Massive osteolysis (acute spontaneous absorption of bone, phantom bone, disappearing bone); its relation to hemangiomatosis. J Bone Joint Surg Am 37-A(5):985–1004CrossRefPubMed Gorham LW, Stout AP (1955) Massive osteolysis (acute spontaneous absorption of bone, phantom bone, disappearing bone); its relation to hemangiomatosis. J Bone Joint Surg Am 37-A(5):985–1004CrossRefPubMed
6.
go back to reference Heffez L et al (1983) Perspectives on massive osteolysis. Report of a case and review of the literature. Oral Surg Oral Med Oral Pathol 55(4):331–343CrossRefPubMed Heffez L et al (1983) Perspectives on massive osteolysis. Report of a case and review of the literature. Oral Surg Oral Med Oral Pathol 55(4):331–343CrossRefPubMed
7.
go back to reference Kokosis G et al (2016) Mandibular reconstruction using the free vascularized fibula graft: an overview of different modifications. Arch Plast Surg 43(1):3–9CrossRefPubMedPubMedCentral Kokosis G et al (2016) Mandibular reconstruction using the free vascularized fibula graft: an overview of different modifications. Arch Plast Surg 43(1):3–9CrossRefPubMedPubMedCentral
8.
go back to reference Abdulai A-E et al (2014) Vanishing bone (Gorham’s) disease of the mandible: a case report. Sch J Med Case Rep 2(3):183–187 Abdulai A-E et al (2014) Vanishing bone (Gorham’s) disease of the mandible: a case report. Sch J Med Case Rep 2(3):183–187
9.
go back to reference Colucci S et al (2006) Gorham-Stout syndrome: a monocyte-mediated cytokine propelled disease. J Bone Miner Res 21(2):207–218CrossRefPubMed Colucci S et al (2006) Gorham-Stout syndrome: a monocyte-mediated cytokine propelled disease. J Bone Miner Res 21(2):207–218CrossRefPubMed
10.
go back to reference Canalis E (2010) Update in new anabolic therapies for osteoporosis. J Clin Endocrinol Metab 95(4):1469–1504CrossRef Canalis E (2010) Update in new anabolic therapies for osteoporosis. J Clin Endocrinol Metab 95(4):1469–1504CrossRef
11.
go back to reference Yuan F (2012) Type 17 T-helper cells might be a promising therapeutic target for osteoporosis. Mol Biol Rep 39(1):771–774CrossRefPubMed Yuan F (2012) Type 17 T-helper cells might be a promising therapeutic target for osteoporosis. Mol Biol Rep 39(1):771–774CrossRefPubMed
12.
go back to reference Zavala-Cerna, M.G., et al. (2015) Osteoprotegerin polymorphisms in a Mexican population with rheumatoid arthritis and generalized osteoporosis: a preliminary report. J Immunol Res 376197 Zavala-Cerna, M.G., et al. (2015) Osteoprotegerin polymorphisms in a Mexican population with rheumatoid arthritis and generalized osteoporosis: a preliminary report. J Immunol Res 376197
13.
go back to reference D’Amico L, R. I. (2012) Cross-talk between T cells and osteoclasts in bone resorption. BoneKEy Reports 1(6) D’Amico L, R. I. (2012) Cross-talk between T cells and osteoclasts in bone resorption. BoneKEy Reports 1(6)
14.
go back to reference Song I et al (2009) Regulatory mechanism of NFATc1 in RANKL-induced osteoclast activation. FEBS Lett 583(14):2435–2440CrossRefPubMed Song I et al (2009) Regulatory mechanism of NFATc1 in RANKL-induced osteoclast activation. FEBS Lett 583(14):2435–2440CrossRefPubMed
15.
go back to reference Hirayama T et al (2001) Cellular and humoral mechanisms of osteoclast formation and bone resorption in Gorham-Stout disease. J Pathol 195(5):624–630CrossRefPubMed Hirayama T et al (2001) Cellular and humoral mechanisms of osteoclast formation and bone resorption in Gorham-Stout disease. J Pathol 195(5):624–630CrossRefPubMed
16.
17.
go back to reference Devlin RD, Bone HG 3rd, Roodman GD (1996) Interleukin-6: a potential mediator of the massive osteolysis in patients with Gorham-Stout disease. J Clin Endocrinol Metab 81(5):1893–1897PubMed Devlin RD, Bone HG 3rd, Roodman GD (1996) Interleukin-6: a potential mediator of the massive osteolysis in patients with Gorham-Stout disease. J Clin Endocrinol Metab 81(5):1893–1897PubMed
18.
go back to reference Rifas L, Weitzmann MN (2009) A novel T cell cytokine, secreted osteoclastogenic factor of activated T cells, induces osteoclast formation in a RANKL-independent manner. Arthritis Rheum 60(11):3324–3335CrossRefPubMedPubMedCentral Rifas L, Weitzmann MN (2009) A novel T cell cytokine, secreted osteoclastogenic factor of activated T cells, induces osteoclast formation in a RANKL-independent manner. Arthritis Rheum 60(11):3324–3335CrossRefPubMedPubMedCentral
19.
go back to reference Jin Z, Li X, Wan Y (2015) Minireview: nuclear receptor regulation of osteoclast and bone remodeling. Mol Endocrinol 29(2):172–186CrossRefPubMed Jin Z, Li X, Wan Y (2015) Minireview: nuclear receptor regulation of osteoclast and bone remodeling. Mol Endocrinol 29(2):172–186CrossRefPubMed
20.
go back to reference D'Amelio P et al (2011) Bone and bone marrow pro-osteoclastogenic cytokines are up-regulated in osteoporosis fragility fractures. Osteoporos Int 22(11):2869–2877CrossRefPubMed D'Amelio P et al (2011) Bone and bone marrow pro-osteoclastogenic cytokines are up-regulated in osteoporosis fragility fractures. Osteoporos Int 22(11):2869–2877CrossRefPubMed
21.
go back to reference Pagliari D et al (2015) The role of “bone immunological niche” for a new pathogenetic paradigm of osteoporosis. Anal Cell Pathol (Amst):434389 Pagliari D et al (2015) The role of “bone immunological niche” for a new pathogenetic paradigm of osteoporosis. Anal Cell Pathol (Amst):434389
22.
go back to reference Moller G, Priemel M (1999) The Gorham-Stout syndrome (Gorham’s massive osteolysis). A report of six cases with histopathological findings. The Journal of bone and joint surgery British 81(5):1893–1897 Moller G, Priemel M (1999) The Gorham-Stout syndrome (Gorham’s massive osteolysis). A report of six cases with histopathological findings. The Journal of bone and joint surgery British 81(5):1893–1897
23.
24.
go back to reference Bonomo A et al (2016) A T cell view of the bone marrow. Front Immunol 17(7):184 Bonomo A et al (2016) A T cell view of the bone marrow. Front Immunol 17(7):184
26.
go back to reference Kon T et al (2001) Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Miner Res 16(6):1004–1014CrossRefPubMed Kon T et al (2001) Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Miner Res 16(6):1004–1014CrossRefPubMed
27.
go back to reference Wiemer AJ et al (2011) A live imaging cell motility screen identifies prostaglandin E2 as a T cell stop signal antagonist. J Immunol 187(7):3663–3670CrossRefPubMedPubMedCentral Wiemer AJ et al (2011) A live imaging cell motility screen identifies prostaglandin E2 as a T cell stop signal antagonist. J Immunol 187(7):3663–3670CrossRefPubMedPubMedCentral
28.
go back to reference Lee SK, Lorenzo J (2006) Cytokines regulating osteoclast formation and function. Curr Opin Rheumatol 18(4):411–418CrossRefPubMed Lee SK, Lorenzo J (2006) Cytokines regulating osteoclast formation and function. Curr Opin Rheumatol 18(4):411–418CrossRefPubMed
29.
go back to reference Franchi A et al (2009) CD105/endoglin expression in Gorham disease of bone. J Clin Pathol 62(2):163–167CrossRefPubMed Franchi A et al (2009) CD105/endoglin expression in Gorham disease of bone. J Clin Pathol 62(2):163–167CrossRefPubMed
30.
go back to reference Pettit AR et al (2008) Osteal macrophages: a new twist on coupling during bone dynamics. Bone 43(6):976–982CrossRefPubMed Pettit AR et al (2008) Osteal macrophages: a new twist on coupling during bone dynamics. Bone 43(6):976–982CrossRefPubMed
31.
go back to reference Jones GB, Midgley RL, Smith GS (1958) Massive osteolysis: disappearing bones. J Bone Joint Surg Br 40B(3):494–501 Jones GB, Midgley RL, Smith GS (1958) Massive osteolysis: disappearing bones. J Bone Joint Surg Br 40B(3):494–501
32.
go back to reference Ray S et al (2012) Vanishing bone disease (Gorhamʼs disease)—a rare occurrence of unknown etiology. Indian J Pathol Microbiol 55(3):399–401CrossRefPubMed Ray S et al (2012) Vanishing bone disease (Gorhamʼs disease)—a rare occurrence of unknown etiology. Indian J Pathol Microbiol 55(3):399–401CrossRefPubMed
33.
go back to reference Fujiu K et al (2002) Chylothorax associated with massive osteolysis (Gorhamʼs syndrome). Ann Thorac Surg 73(6):1956–1957CrossRefPubMed Fujiu K et al (2002) Chylothorax associated with massive osteolysis (Gorhamʼs syndrome). Ann Thorac Surg 73(6):1956–1957CrossRefPubMed
34.
go back to reference Bickel WH, Brodere AC (1947) Primary lymphangioma of the ilium; report of a case. J Bone Joint Surg Am 29(2):517–522PubMed Bickel WH, Brodere AC (1947) Primary lymphangioma of the ilium; report of a case. J Bone Joint Surg Am 29(2):517–522PubMed
35.
37.
go back to reference Situma M et al An aggressive lymphatic malformation (Gorhamʼs disease) leading to death of a child. J Pediatr Surg 48(1):239–242 Situma M et al An aggressive lymphatic malformation (Gorhamʼs disease) leading to death of a child. J Pediatr Surg 48(1):239–242
39.
go back to reference Tammela T, Alitalo K (2010) Lymphangiogenesis: molecular mechanisms and future promise. Cell 140(4):460–476CrossRefPubMed Tammela T, Alitalo K (2010) Lymphangiogenesis: molecular mechanisms and future promise. Cell 140(4):460–476CrossRefPubMed
40.
go back to reference Huber S et al (2007) Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis. Kidney Int 71(8):771–777CrossRefPubMed Huber S et al (2007) Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis. Kidney Int 71(8):771–777CrossRefPubMed
41.
go back to reference Kärpänen T et al (2006) Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. FASEB J 20(9):1462–1472CrossRefPubMed Kärpänen T et al (2006) Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. FASEB J 20(9):1462–1472CrossRefPubMed
Metadata
Title
Gorham-Stout Disease: a Clinical Case Report and Immunological Mechanisms in Bone Erosion
Authors
Maria José Franco-Barrera
Maria Guadalupe Zavala-Cerna
Georgina Aguilar-Portillo
Diana Brisa Sánchez-Gomez
Olivia Torres-Bugarin
Miguel Angel Franco-Barrera
Carlos Manuel Roa-Encarnacion
Publication date
01-02-2017
Publisher
Springer US
Published in
Clinical Reviews in Allergy & Immunology / Issue 1/2017
Print ISSN: 1080-0549
Electronic ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-016-8594-z

Other articles of this Issue 1/2017

Clinical Reviews in Allergy & Immunology 1/2017 Go to the issue